Self-assembled cellulose-based hydrogels are a new type of supramolecular architecture with potential in biomedical applications. By our preparation, hydrophobic lauryl side-chains were grafted onto hydroxyethyl cellulose (HEC-C 12 ) and ibuprofen molecules were encapsulated and solubilized by poly In addition, the Korsmeyer-Peppas kinetic model gave a better correlation for the release of IBU, and the release procedure was a non-Fickian diffusion process.
Introduction
Hydrogels are a kind of three-dimensional network which consists of covalently crosslinked hydrophilic polymers, and may absorb many times their dry weight of water without being dissolved. [1] [2] [3] In recent years, hydrogels have been widely studied due to their promising applications in cosmetics, biomaterials, drug delivery systems, wastewater purication, and so on.
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Among them, considerable research attention has been focused on CD-based hydrogels. As we know, CDs are non-reducing cyclic maltooligosaccharides produced from starch by cyclodextrin glycosyltransferase and are composed of hydrophilic outer surfaces and hydrophobic inner cavities. [11] [12] [13] [14] [15] [16] This structure with its remarkable abilities can form inclusion complexes with a wide range of guest moieties and hydrophobic side chains, [17] [18] [19] [20] [21] [22] [23] which is a supramolecular interaction without covalent bonds. Therefore, CD-based hydrogels have become one of the most widely studied functional hydrogels in the eld of self-assembly, 24, 25 especially in biomedical and pharmaceutical elds.
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In many application elds, ordinarily traditional gels are based on organic synthetic polymers, such as poly(acrylamide), poly(2-hydroxyethylacrylate), poly(2-hydroxymethylacrylamide), poly(hydroxyethyl methacrylate) and so on. [30] [31] [32] Synthetic polymers are non-biodegradable, and the commercialization of these organic synthetic polymer gels is usually limited by the fact that the preparation of the polymer matrices requires large amounts of potentially toxic organic solvents, which are oen not able to meet the severe requirements of applications in drug delivery, bio-pharmaceuticals and so on. Herein, HEC, which is a kind of non-ionic cellulose ether with good water solubility and can be easily manufactured using natural cellulose as a raw material, is used as the hydrogel matrix, instead of synthetic polymers, taking advantage of cellulose resources, including its renewable nature, biocompatibility and biodegradability. [33] [34] [35] To our knowledge, no studies have been performed on the formation of self-assembled supramolecular hydrogels between hydrophobically modied HEC and b-CDP.
Ibuprofen, a non-steroidal anti-inammatory drug, is usually formulated into many topical preparations to reduce the adverse side effects and avoid hepatic rst-pass metabolism. But it is difficult to maintain effective concentrations by topical delivery due to its poor skin permeation ability. 36 So far, hydrogel matrices such as carbomer 940, 37 xanthan gum, 38, 39 carrageenan, 37 dextran 22 and cellulose 40 have been used to increase the viscosity of hydrogels for the topical application of IBU. 37 However, there are few reports that utilize self-assembly methods to prepare IBU hydrogels, especially CD based hydrogels. Owing to its simple preparation using the technique of self-assembly and the intrinsic advantages for drug delivery from CD, the loading of IBU by CD in a hydrogel through the technique of self-assembly is no doubt a desirable subject of study, whether in theory or in practice. In that case, the purpose of this study is to focus on the synthesis of a self-assembled IBUloaded hydrogel based on CDs and HEC. According to the literature, IBU is a functional molecule that is efficacious in restraining so-tissue pain and osteoarthritis. However, the hydrophobic properties of IBU restrain its distribution in hydrogels, which decreases the bioavailability in medical applications. Therefore the solubility of IBU was enhanced through formation of inclusion complexes with b-CDP. First, HEC-C 12 and b-CDP were synthesized in a controlled manner. Then, IBU was encapsulated by b-CDP and the content of active residual cavities in b-CDP in b-CDP/IBU was determined. Aer that, the HEC based gel-(b)CDP-HEC/IBU was obtained just in aqueous solution due to the self-assembly process between the C 12 side-chains and the residual hydrophobic cavities of b-CDP, with the IBU drug encapsulated in b-CDP, as mentioned previously. Hence, the synthesized novel gel-(b)CDP-HEC/IBU was a safe, nonirritating, biocompatible and biodegradable hydrogel for biomedical applications. Subsequently, the IBU-loading content, swelling and the in vitro release characteristics were evaluated.
Experimental
Materials HEC (720 000 g mol À1 , DS ¼ 1.0-1.2, MS ¼ 2.5) was purchased from Sigma-Aldrich Co., Ltd., USA. b-CD (1135 g mol À1 , >98%), IBU (206.28 g mol À1 , >98%), 1-chlorododecane (C 12 , AR), EPI (AR) and phenolphthalein (AR) were obtained from Aladdin Industrial Co., Ltd., China. N,N-Dimethylacetamide (DMAc, AR), lithium chloride (LiCl, AR), pyridine (AR) and sodium hydroxide (NaOH, AR) were supplied by Kermel Chemical Reagent Co., Ltd., China. Other reagents were used without further purication.
Preparation of HEC-C 12
HEC-C 12 was synthesized using a Williamson etherication reaction. 22 2 g of HEC was added to 80 mL of DMAc (2 g of LiCl was mixed in for solubilization) at 80 C, and the mixture was dissolved under continuous mechanical stirring for 24 h. Then 0.68 mL of pyridine and 2 mL of 1-chlorododecane were added to the HEC solution successively. Aer 8 h of stirring at 80 C, the solution was cooled to room temperature. Subsequently, it was poured into a dialysis bag (MWCO 8-12 kDa, Biosharp, USA) and dialyzed for 7 days. Finally, the products were obtained by freeze drying.
Preparation of b-CDP
b-CDP was synthesized by reaction of b-CD with EPI in alkaline environment. [41] [42] [43] [44] First, 10 g of b-CD was dissolved in 15 mL of 15 wt% NaOH by stirring overnight at room temperature. Then the mixture was heated to 35 C and 7 mL of EPI was added in a 1 : 10 b-CD : EPI molar ratio. Aer 200 min, the mixture was poured into a dialysis bag (MWCO 8-12 kDa, Biosharp, USA) and dialyzed for 7 days. Finally, the products were obtained by freeze drying.
Solubilization of IBU by b-CDP
The hydrophobic IBU molecules were encapsulated in the selfassembled hydrogel by formation of inclusion complexes with b-CDP before mixing with HEC-C 12 , and the solubility of IBU could be enhanced in this way at the same time. Phase solubility studies were carried out in water at room temperature according to the method described by Higuchi and Connors. 45 An excess amount of IBU was mixed with aqueous solutions containing increasing amounts of b-CDP. The suspensions were stirred at room temperature for 24 h to reach equilibrium. Then the solutions were ltered and the ltrate was lyophilized to obtain the synthesized b-CDP/IBU. The concentration of IBU in solution was determined using a UV spectrophotometer (TU1901, Persee, China) at a wavelength of 219 nm according to the calibration curve of IBU. The solubility of IBU in the b-CDP solution was calculated and the phase-solubility diagram for the solubility of IBU versus concentration of b-CDP was plotted. All experiments were performed in triplicate. 46 The apparent stability constant (K 1 : m ) can be determined from the phasesolubility diagrams.
Determination of active residual cavities of b-CDP in b-CDP/ IBU
The content of active residual cavities in b-CDP with inclusion abilities in b-CDP/IBU can be determined by the phenolphthalein probe method, as our previous work mentioned. 47, 48 For determination, 0.02 g of dried b-CDP/IBU was dissolved in 5 mL of 10 À3 mol L À1 phenolphthalein in a 50 mL comparison tube and then 15 mL of a Na 2 CO 3 -NaHCO 3 buffer solution (pH ¼ 10.5) was added. The mixed solution was kept in the dark and stirred for 12 h for complete inclusion equilibrium. Aer that, the solution was transferred to a 200 mL volumetric ask, and diluted with a Na 2 CO 3 -NaHCO 3 buffer solution (pH ¼ 10.5) to volume. Then the content of active residual cavities in b-CDP in b-CDP/IBU was determined using a UV spectrophotometer (TU1901, Persee, China) at a wavelength of 553 nm. CDP and gel-(b)CDP-HEC/IBU were also characterized using 1 H NMR spectroscopy. It was performed using a 400 MHz Bruker Avance III HD 400 (Bruker, Germany) spectrometer at room temperature, using tetramethylsilane and DMSO-d 6 as the internal standard and solvent, respectively.
FTIR. The structural properties of HEC, HEC-C 12 , b-CD, b-CDP, IBU and gel-(b)CDP-HEC/IBU were characterized by FTIR spectroscopy. It were performed using potassium bromide pellets and recorded using a Nicolet IS10 spectrometer (Thermo Fisher Scientic, USA), with a wavenumber range from 4000-400 cm À1 and a resolution of 4 cm À1 for 32 scans.
GPC. The molecular weight distributions of the synthesized water soluble b-CDP were determined using GPC on a connecting GPC column: TSK gel G4000PWXL (TOSOH, Tokyo, Japan). Milli-Q water was selected as the mobile phase, and the ow rate was set at 0.5 mL min
À1
. Molecular weight calculation soware was connected to the HPLC integration system (Shimadzu LC-10AD, Kyoto, Japan). GPC peaks were detected with a refractive index detector (Waters 410, Milford, MA, USA) and polyethylene oxide/glycol easivials were chosen as the standard substance.
SEM. The surface morphologies of the synthesized HEC, HEC-C 12 , b-CD, b-CDP, IBU, b-CDP/IBU and gel-(b)CDP-HEC/ IBU were characterized by SEM. Micrographs were obtained using JSM-7500F (JEOL, Japan) equipment with an acceleration voltage of 15 kV and the sample was coated with a thin layer of gold before observation.
PXRD. The PXRD patterns for IBU, b-CDP/IBU and gel-(b) CDP-HEC/IBU were recorded using an X'Pert3 Powder X-ray diffractometer (PANalytical, Netherlands) with monochromatic Cu-Ka radiation (l ¼ 1.540598Å). The voltage and current were 40 kV and 40 mA. The 2q range was 5 to 90 in steps of 0.013 with a count time of 100 s.
Freeze drying. The synthesized products were all freeze-dried for 24 h to obtain dried samples using a SJIA-10N freezer dryer (Shuangjia, China). The characterization of the nal product gel-(b)CDP-HEC/IBU was performed in the xerogel state.
Swelling and IBU in vitro release studies
Swelling studies of gel-(b)CDP-HEC/IBU were carried out by a gravimetric method. A dry hydrogel sample was weighed (recorded as W d (g)) and allowed to swell in phosphate-buffered saline buffer solution (PBS, 0.1 mmol L À1 , pH ¼ 7.4) at 37 C.
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At different time intervals, the swelling hydrogel was removed from the aqueous solution and its surface was dried with a lter paper, the weight was measured as W s (g). The swelling ratio (SR) of the hydrogel at different time intervals is determined using eqn (1) 50 and the values of SR were measured and calculated in triplicate.
In vitro release of IBU was carried out using a dialysis bag diffusion technique.
51-53 PBS buffer solution (0.1 mmol L À1 , pH 7.4) was used as the release medium. 54 For the release experiment, a control group HEC-C 12 /IBU was synthesized by dissolving 0.5 g of HEC-C 12 in a mixed solution of 20 mL of water and 20 mL of 250 mg L À1 IBU ethanol solution. The obtained HEC-C 12 /IBU was freeze-dried to get a dry product. Aer that, 0.1 g of gel-(b)CDP-HEC/IBU and HEC-C 12 /IBU were dissolved in 20 mL of distilled water, separately. Each solution was transferred to a dialysis bag (MWCO 12-14 kDa, Biosharp, USA) with the two ends xed by clips and then placed in a preheated release medium (50 mL) at 37 C under moderate stirring. At different time intervals, 1 mL of the external medium was withdrawn and then an equal volume of fresh medium was added.
Kinetic study of swelling and IBU release
Based on the relative rate of diffusion of water into the hydrogel matrix and the rate of polymer chain relaxation, the swelling of the polymers and the IBU release prole from gel-(b)CDP-HEC/ IBU could be simulated by four kinetic models, 55-57 the models are listed below.
The zero order kinetic model:
The rst order kinetic model:
The Higuchi kinetic model is widely used to describe the empirical process of drug delivery, which complies with Fick's law and can be expressed as:
The Korsmeyer and Peppas kinetic model described the rst 60 wt% of the release behavior of a hypothetical distribution, and it attempts to explain release mechanisms where erosion and/or dissolution of the matrix occurs and is represented as follows:
where M t /M N is the cumulative release efficiency of IBU in a time interval t (min),
, and
are the constant release rates of the four kinetic models, respectively, C 0 , C 1 , and C H are the intercepts of eqn (2) to (4), respectively, and n is an exponent that indicates the mechanism by which the drug release process occurs. When the value of n is equal to 0.5, drug release occurs through a diffusion phenomenon, Fickian type. When the value of n is between 0.5 and 1, drug release is caused by a non-Fickian mechanism or anomalous diffusion, and when the value of n equals 1, the mechanism of drug release depends on the process of relaxation of the polymer chains.
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Results and discussion
Characterization of HEC-C 12
The hydrophobic C 12 side-chains are graed onto HEC using a Williamson etherication reaction, and the graing of the C 12 side-chains on HEC was characterized using 1 SEM analysis. The surface morphology of HEC and HEC-C 12 recorded using SEM is shown in Fig. 3a and b, respectively. The SEM image of HEC (Fig. 3a) shows a compact thin colloidal structure, while that of HEC-C 12 (Fig. 3b) shows a porous surface with a dendritic structure on the side. This indicates that the introduction of C 12 changes the apparent appearance of HEC.
Characterization of b-CDP
GPC analysis. b-CDP was crosslinked by EPI in 15 wt% NaOH aqueous solution, and GPC was used to test the molecular weight distribution of the synthesized b-CDP. The retention time (t R ) and the weight-average molecular weight (M w ) were determined to be 11.484 min and 1731.1 kDa, respectively, as shown in Fig. 4 . The results demonstrate that the degree of polymerization of b-CDP is around 1500. According to the research of Renard and Koopmans, 42,43 an almost linear copolymer of b-CDP with a suitable degree of polymerization is obtained by carefully controlling the synthesis conditions in order to obtain high water solubility and excellent encapsulation activity.
FTIR analysis. FTIR spectra of b-CD and b-CDP are shown in Fig. 5a and b, respectively. Comparing Fig. 5a with 5b, the band at 3397 cm À1 , corresponding to O-H stretching vibrations, is blue shied to 3423 cm À1 , which is attributed to the breaking of hydrogen bonds resulting from the polymerization of b-CD. In addition, the O-H in-plane bending vibration and out-of-plane bending vibration at 1654 cm À1 , 707 cm À1 and 756 cm À1 in Fig. 5b are decreased compared to those of Fig. 5a , while the C-O-C stretching vibrations at 1034 and 1084 cm À1 are increased, in contrast. These phenomena are due to the breaking and rearrangement of hydrogen bonds during the polymerization process. SEM analysis. The SEM image of b-CD shown in Fig. 3c shows petal shaped debris, while aer polymerization, the synthesized b-CDP in Fig. 3d exhibits a compact layered 
Phase solubility studies
Phase-solubility diagrams are widely used for studying hydrophobic drug/CD complexes because they provide information on both the solubilizing ability of CDs and the apparent stability constants of the inclusion complexes. 45, 62, 63 The solubilized IBU concentration was calculated according to the calibration curve of IBU, which is established as seen in eqn (6), with a correction coefficient (R 2 ) of 0.9986:
where A denotes the absorbance of the diluted IBU, and c IBU represents the concentration of the diluted IBU (mol L
À1
). From 
where the slope is the value given by the linear regression, and S 0 is the solubility of IBU in the absence of b-CDP in aqueous solution, which is also given by the linear regression (mmol L
). The CDP/IBU inclusion complexes. The physical maps of the solubilized IBU and its control group without the addition of b-CDP are shown in Fig. 7a and b, respectively.
Inclusion ability of the active residual cavities of b-CDP in b-CDP/IBU
As mentioned above, IBU molecules can be encapsulated into the cavities contained in b-CDP. However, the question is whether or not b-CDP/IBU still has the inclusion ability to form self-assembled hydrogels with HEC-C 12 . The answer is given by the detection results of the phenolphthalein probe method. Due to the decolorization of purple phenolphthalein upon complexation with b-CD at pH ¼ 10.5, the content of active residual cavities in b-CDP with inclusion abilities in b-CDP/IBU can be determined.
The calibration curve of active b-CD is seen in eqn (8) , the h values of the mixtures changed a lot, especially at concentrations of HEC-C 12 ranging from 30 mg mL À1 to 40 mg mL À1 . It can be inferred that enough hydrophobic C 12 side-chains are the requirement for forming hydrogel polymer networks due to CD inclusion chemistry. When the concentration of HEC-C 12 was 30 mg mL À1 , the h value showed a signicant increase compared to that without the addition of b-CDP/IBU. This result demonstrates that the critical concentration of HEC-C 12 for forming self-assembled hydrogels can be xed at 30 mg mL À1 .
The self-assembly process is represented in Fig. 9 . In 2.42 ppm, and a double peak at d 7.10 ppm and 7.18 ppm, which are attributed to the framework protons of the IBU molecule. Also in Fig. 10c , the framework protons of HEC-C 12 (Fig. 1b) and b-CDP (Fig. 10b) can be observed. Due to the different solubilities of IBU, HEC-C 12 and b-CDP in DMSO-d 6 , the encapsulation efficiency of IBU by gel-(b)CDP-HEC/IBU cannot be calculated using the results of 1 H NMR spectroscopy. in Fig. 11a is attributed to the C-O groups of IBU, but that in Fig. 11b is obviously weakened. This phenomenon demonstrates that IBU is introduced into the synthesized product of gel-(b)CDP-HEC/IBU but the loading amount is small. Furthermore, the FTIR spectrum of gel-(b)CDP-HEC/IBU (Fig. 11b) has the characteristic infrared peaks of HEC-C 12 ( Fig. 2b) and b-CDP (Fig. 5b) , this result probably proves that such a method for the synthesis of gel-(b)CDP-HEC/IBU is feasible.
SEM analysis. With the addition of IBU, the SEM morphology of b-CDP/IBU (Fig. 3f) shows a sparse surface with irregular colloidal thin slices on the sides. The morphology of gel-(b)CDP-HEC/IBU (Fig. 3g) demonstrates a uffy debris on the sides and the surface of gel-(b)CDP-HEC/IBU is as compact as that of HEC-C 12 (Fig. 3b) . Both the two "new substances" show a homogenous amorphous structure with a complete absence of the characteristic plate shaped crystals of IBU (Fig. 3e) . This change in the native morphology is suggestive of a possible interaction between IBU and b-CDP in gel-(b)CDP-HEC/IBU. PXRD analysis. From PXRD of the samples (Fig. 12) , the diffractogram of IBU (Fig. 12a) can be seen to show typical sharp peaks at 6.10 , 16.67 , and 22.32 and several minor peaks on the 2q scale, while those patterns of b-CDP/IBU (Fig. 12b ) and gel-(b)CDP-HEC/IBU (Fig. 12c ) don't show any sharp peaks, which conrms their amorphous nature. In addition, new peaks are observed at 11.82 and 18.65 in Fig. 12b and at 11. The swelling of hydrogels has a great effect on the rate of drug release. Diffusion-controlled drug release increases with an increase in the swelling of the hydrogel. 67 Therefore, in order to better understand the IBU release mechanism, the swelling characteristics of gel-(b)CDP-HEC/IBU were investigated. The swelling prole at different time intervals is shown in Fig. 13 . From the graph it can be seen that the values of SR for gel-(b) In vitro release characteristics of IBU in gel-(b)CDP-HEC/IBU were investigated. The released IBU content can be detected by a UV spectrophotometer (TU1901, Persee, China) at a wavelength of 219 nm according to the calibration curve of IBU as described above and the IBU cumulative release efficiency (R, wt%) was calculated using eqn (11). In addition, in order to determine the IBU release kinetic model describing the release mechanism, Origin 8.0 soware was used. ANOVA analysis and the kinetic parameters for the different kinetic models were determined by linear and nonlinear curve ttings and the results are summarized in Table 1 . From Table 1 , the ANOVA results "Prob > F" for the four kinetic models are all far lower than 0.05, and it can be concluded that all the tted curves in the experimental design are statistically signicant at a 95% condence level. Moreover, the value of the correction coefficient R 2 for the Korsmeyer and
Peppas kinetic model is extremely high (>0.99), greater than those of the zero order, rst order and Higuchi models. Hence, the kinetic model of Korsmeyer and Peppas gives better correlation for the release of IBU from gel-(b)CDP-HEC/IBU. Furthermore, the diffusion exponent "n" was calculated as 0.8731, which is between 0.5 and 1, so the release procedure is a non-Fickian diffusion process. Such results indicate that aer swelling, IBU release occurs through the combination of both diffusion and erosion of gel-(b)CDP-HEC/IBU.
Conclusions
A novel self-assembled, drug loaded gel-(b)CDP-HEC/IBU was synthesized through host-guest interactions. Hydrophobic IBU molecules were solubilized and encapsulated by b-CDP and the content of residual cavities in b-CDP with inclusion abilities in b-CDP/IBU was determined to be 31.3 wt%. In the hydrogel selfassembly process, the residual cavities provided binding sites for associating with HEC-C 12 and the hydrogel demonstrates a high viscosity when the concentrations of HEC-C 12 and b-CDP/ IBU are xed at 30 mg mL À1 and 35 mg mL À1 , respectively.
Moreover, the encapsulated IBU content in gel-(b)CDP-HEC/IBU was detected as 5 wt%, and gel-(b)CDP-HEC/IBU presents the signicant sustained release of IBU over 1440 min, for which gel-(b)CDP-HEC/IBU has potential application value in restraining so-tissue pain and osteoarthritis. In addition, aer swelling, the release of IBU from gel-(b)CDP-HEC/IBU complies with the Korsmeyer and Peppas kinetic model and is a nonFickian diffusion process; in that case, the release mechanism is the synergistic effect of erosion and dissolution of the gel-(b) CDP-HEC/IBU matrix.
